Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
29 Sep 2013 ECC 2013 Press Release: Everolimus Slows Disease Progression in Advanced Papillary Kidney Cancer Patients Genitourinary cancers - Anticancer agents & Biologic therapy
29 Sep 2013 ECC 2013 Press Release: Identifying the Disease-Causing Mechanisms in Cancers with an Unknown Primary Site Improves Treatment and Survival Pathology/Molecular biology - Carcinoma of unknown primary site
28 Sep 2013 ESMO @ ECC 2013: Vemurafenib in Patients With RAI Refractory, Progressive, BRAFV600E-mutated Papillary Thyroid Cancer Endocrine cancers - Anticancer agents & Biologic therapy
28 Sep 2013 ESMO @ ECC 2013: Belagenpumatucel-L Therapeutic Tumour Cell Vaccine for Non-Small Cell Lung Cancer Lung and other thoracic tumours - Immuno-oncology
28 Sep 2013 ESMO @ ECC 2013: Phase III FIRE-3 Trial Data Show Most Patients with Wild-Type RAS Metastatic Colorectal Cancer Benefit from First-Line FOLFIRI Plus Cetuximab Treatment Personalised medicine - Gastrointestinal cancers - Anticancer agents & Biologic therapy
28 Sep 2013 ECC 2013 Press Release: Treating Chest Lymph Nodes in Patients with Early Breast Cancer Improves Survival Without Increasing Side Effects Breast cancer
28 Sep 2013 ECC 2013 Press Release: Hyperfractionated Radiotherapy Improves Survival in Head and Neck Cancer Patients Head and neck cancers
28 Sep 2013 ESMO @ ECC 2013: Premenopausal High-Risk Breast Cancer Patients with Luminal A Tumours Benefit from Postmastectomy Radiation Breast cancer
28 Sep 2013 ECC 2013 Press Release: Advanced melanoma: Pooled analysis of long-term survival with ipilimumab Melanoma - Immuno-oncology
28 Sep 2013 ECC 2013 Press Release: Anti-Cancer Drug T-DM1 Benefits Women with Avanced Breast Cancer who have Failed Several Previous Treatments: Results from TH3RESA Trial Breast cancer - Anticancer agents & Biologic therapy
26 Sep 2013 European Medicines Agency Recommends a Variation to the Terms of the Marketing Authorisation for Everolimus Central nervous system malignancies - Anticancer agents & Biologic therapy
25 Sep 2013 European Medicines Agency Recommends to Extend the Indications for Ipilimumab Melanoma - Anticancer agents & Biologic therapy
24 Sep 2013 RAS Mutations Predict a Lack of Response in Patients with Metastatic Colorectal Cancer who Receive Panitumumab–FOLFOX4 Personalised medicine - Gastrointestinal cancers
23 Sep 2013 European Medicines Agency Recommends Granting a Marketing Authorisation for Radium-223 Chloride Genitourinary cancers - Anticancer agents & Biologic therapy
23 Sep 2013 European Medicines Agency Recommends Granting a Marketing Authorisation for Trastuzumab Emtansine Breast cancer - Anticancer agents & Biologic therapy